270 related articles for article (PubMed ID: 26106067)
1. Engineering trypsin for inhibitor resistance.
Batt AR; St Germain CP; Gokey T; Guliaev AB; Baird T
Protein Sci; 2015 Sep; 24(9):1463-74. PubMed ID: 26106067
[TBL] [Abstract][Full Text] [Related]
2. Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator.
Yang SQ; Craik CS
J Mol Biol; 1998 Jun; 279(4):1001-11. PubMed ID: 9642077
[TBL] [Abstract][Full Text] [Related]
3. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
Ma LC; Anderson S
Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
[TBL] [Abstract][Full Text] [Related]
4. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
[TBL] [Abstract][Full Text] [Related]
6. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
Krokoszynska I; Dadlez M; Otlewski J
J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
[TBL] [Abstract][Full Text] [Related]
7. Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates.
Alloy AP; Kayode O; Wang R; Hockla A; Soares AS; Radisky ES
J Biol Chem; 2015 Aug; 290(35):21523-35. PubMed ID: 26175157
[TBL] [Abstract][Full Text] [Related]
8. Rigidification of a flexible protease inhibitor variant upon binding to trypsin.
Hanson WM; Domek GJ; Horvath MP; Goldenberg DP
J Mol Biol; 2007 Feb; 366(1):230-43. PubMed ID: 17157870
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of binding of P1 variants to trypsin.
Brandsdal BO; Aqvist J; Smalås AO
Protein Sci; 2001 Aug; 10(8):1584-95. PubMed ID: 11468355
[TBL] [Abstract][Full Text] [Related]
10. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
Liu Y; Breslauer K; Anderson S
Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
[TBL] [Abstract][Full Text] [Related]
11. Comparison of complexes formed by a crustacean and a vertebrate trypsin with bovine pancreatic trypsin inhibitor - the key to achieving extreme stability?
Molnár T; Vörös J; Szeder B; Takáts K; Kardos J; Katona G; Gráf L
FEBS J; 2013 Nov; 280(22):5750-63. PubMed ID: 24034223
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationship of serine protease-protein inhibitor interaction.
Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
[TBL] [Abstract][Full Text] [Related]
13. Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin.
Cohen I; Coban M; Shahar A; Sankaran B; Hockla A; Lacham S; Caulfield TR; Radisky ES; Papo N
J Biol Chem; 2019 Mar; 294(13):5105-5120. PubMed ID: 30700553
[TBL] [Abstract][Full Text] [Related]
14. Presence versus absence of hydrogen bond donor Tyr-39 influences interactions of cationic trypsin and mesotrypsin with protein protease inhibitors.
Salameh MA; Soares AS; Alloy A; Radisky ES
Protein Sci; 2012 Aug; 21(8):1103-12. PubMed ID: 22610453
[TBL] [Abstract][Full Text] [Related]
15. The structure of a Michaelis serpin-protease complex.
Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ
Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246
[TBL] [Abstract][Full Text] [Related]
16. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
Azim MK; Grossmann JG; Zaidi ZH
J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
[TBL] [Abstract][Full Text] [Related]
17. NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition.
Cabrera-Muñoz A; Valiente PA; Rojas L; Alonso-Del-Rivero Antigua M; Pires JR
J Struct Biol; 2019 Jun; 206(3):280-294. PubMed ID: 30930219
[TBL] [Abstract][Full Text] [Related]
18. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
Ang MJ; Lim HA; Poulsen A; Wee JL; Ng FM; Joy J; Hill J; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(sup2):194-200. PubMed ID: 27241372
[TBL] [Abstract][Full Text] [Related]
19. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
Popov EM; Godzhaev NM; Aliev RE
Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin.
Salameh MA; Soares AS; Hockla A; Radisky ES
J Biol Chem; 2008 Feb; 283(7):4115-23. PubMed ID: 18077447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]